Latest News May 14, 2024 Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET® May 10, 2024 Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) View All News Dark Blue View All News Show all Latest Quarterly Results First Quarter 2024 Financial Results Esperion Reports First Quarter 2024 Financial Results Esperion Q1 Earnings Presentation 1.9 MB Form 10-Q View All Earnings View All Earnings Corporate Presentation Download PDF Investor Events Upcoming Events May 20, 2024 at 10:00 AM EDT H.C. Wainwright’s 2nd Annual BioConnect Investor Conference May 23, 2024 at 8:00 AM EDT Esperion Therapeutics, Inc. 2024 Annual Meeting of Stockholders Past Events May 15, 2024 at 3:00 PM PDT Bank of America Securities’ 2024 Health Care Conference May 13, 2024 at 2:30 PM EDT JMP Securities’ Life Sciences Conference View All Events View All Events
May 14, 2024 Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET®